In This Section

AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology

Nomination StatusOpen
Nomination DeadlineJuly 31, 2020
Generously Supported ByThe Cancer Research Institute
Description
  • The AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research has had a major impact on the cancer field and has the potential to stimulate new directions in cancer immunology. All areas of cancer immunology will be considered for this award.
  • The Award recipient will receive an honorarium and present an award lecture during the AACR Annual Meeting 2021 in Washington, DC.
Eligibility Criteria
  • The Award is open to a cancer immunologist affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.
  • Candidates must currently maintain an active research program, have a record of recent publications, and be able to present an award lecture at the AACR Annual Meeting 2021.
  • The Award will be presented to an individual investigator.
  • Institutions and/or organizations are not eligible to receive the Award.
Contact Information
Nomination Criteria

Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Self-nominations are prohibited.

Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically. Paper nominations will not be accepted.

See the Program Guidelines and Nomination Instructions for complete details.

Selection Process

Eligible candidates will be considered on the basis of their outstanding and innovative research, which has had a major impact on the cancer field, and which has the potential to stimulate new directions in cancer immunology.

Eligible nominees will be considered by an Award Selection Committee composed of an international cohort of cancer research experts appointed by the AACR President in consultation with the Cancer Research Institute’s leadership. After Award Committee deliberations, primary and alternate award recipient recommendations will be relayed to the AACR Executive Committee for formal ratification.

Selection of the Award recipient shall be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.